Astrana Health earnings were $43.1M for the trailing 12 months ending Dec 31, 2024, with -30% growth year over year. The latest ASTH earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$7.0M, down 143.2% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, ASTH reported annual earnings of $43.1M, with -28.9% growth.
ASTH past earnings growth
How has ASTH's earnings growth performed historically?
On ASTH's earnings call on Invalid Date, Astrana Health (NASDAQ: ASTH) reported Q4 2024 earnings per share (EPS) of -$0.14, up 153.85% year over year. Total ASTH earnings for the quarter were -$6.95 million. In the same quarter last year, Astrana Health's earnings per share (EPS) was $0.26.
As of the last Astrana Health earnings report, Astrana Health is currently profitable. Astrana Health's net profit (also called net income) for the twelve months ending Dec 31, 2024 was $43.15 million, a 28.93% decrease year over year.
What was ASTH's earnings growth in the past year?
As of Astrana Health's earnings date in Invalid Date, Astrana Health's earnings has grown -30% year over year. This is 44.55 percentage points lower than the US Medical Care Facilities industry earnings growth rate of 14.55%. ASTH earnings in the past year totalled $43.15 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.